Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Fig. 3

Overall survival and relapse-free survival according to IDH mutation status and allogeneic hematopoietic cell transplantation in CR1. Simon–Makuch plots for a overall survival and b relapse-free survival of AML patients with IDH wildtype (WT) or mutated (mut) IDH treated with allogeneic hematopoietic cell transplantation (blue for IDHWT and violet for IDHmut) or conventional consolidation (red for IDHWT and green for IDHmut), respectively; p-values were determined with Cox model with time-dependent modeling of alloHCT; time in months

Back to article page